[1] Xie JJ, Wu ZY. Wilson'sdisease in China. Neurosci Bull, 2017, 33(3): 323-330. [2] Smolinski L, Litwin T, Redzia-Ogrodnik B, et al. Brain volume is related to neurological impairment and to copper overload in Wilson's disease. Neurol Sci, 2019, 40(10): 2089-2095. [3] Doganay S, Gumus K, Koc G, et al. Magnetic susceptibility changes in the basal ganglia and brain stem of patients with Wilson's disease: Evaluation with quantitative susceptibility mapping. Magn Reson Med Sci, 2018, 17(1): 73-79. [4] Akhan O, Akpinar E, Karcaaltincaba M, et al. Imaging findings of liver involvement of Wilson's disease. Eur J Radiol, 2009, 69(1): 147-155. [5] Yu XE, Gao S, Yang RM, et al. MR imaging of the brain in neurologic Wilson disease. Am J Neuroradiol, 2019, 40(1): 178-183. [6] Paternostro R, Pfeiffenberger J, Ferenci P, et al. Non-invasive diagnosis of cirrhosis and long-term disease monitoring by transient elastography in patients with Wilson disease. Liver Int, 2020[ahead of print] . [7] Özdemir M, Ökten RS, Küçükay F, et al. Multidetector computed tomography findings of splenic artery aneurysms associated with liver involvement in Wilson's disease. Transplant Proc, 2017, 49(8): 1806-1809. [8] Zhong HJ, Sun HH, Xue LF, et al. Differential hepatic features presenting in Wilson disease-associated cirrhosis and hepatitis B-associated cirrhosis. World J Gastroenterol, 2019, 25(3): 378-387. [9] Poujois A, Woimant F. Wilson's disease: A 2017 update. Clin Res Hepatol Gastroenterol, 2018, 42(6): 512-520. [10] Zhong W, Huang Z, Tang X. A study of brain MRI characteristics and clinical features in 76 cases of Wilson's disease. J Clin Neurosci, 2019, 59: 167-174. [11] Zhou ZH, Wu YF, Cao J, et al. Characteristics of neurological Wilson's disease with corpus callosum abnormalities. BMC Neurol, 2019, 19(1): 85. [12] Song YK, Li XB, Huang XL, et al. A study of neurite orientation dispersion and density imaging in wilson's disease. J Magn Reson Imaging, 2018, 48(2): 423-430. [13] Dezortova M, Lescinskij A, Dusek P, et al. Multiparametric quantitative brain MRI in neurological and hepatic forms of Wilson's disease. J Magn Reson Imaging, 2019 [ahead of print] . [14] Dusek P, Skoloudik D, Maskova J, et al. Brain iron accumulation in Wilson's disease: A longitudinal imaging case study during anticopper treatment using 7.0T MRI and transcranial sonography. J Magn Reson Imaging, 2018, 47(1): 282-285. [15] Alkhalik Basha MA, Refaat R, Ahmed AF, et al. Brain magnetic resonance spectroscopy (MRS) as a diagnostic tool for detecting early neurological changes in children with Wilson's disease. Eur J Radiol, 2019, 111: 41-46. [16] Zhou XX, Li XH, Chen DB, et al. The asymmetry of neural symptoms in Wilson's disease patients detecting by diffusion tensor imaging, resting-state functional MRI, and susceptibility-weighted imaging. Brain Behav, 2018, 8(5): e00930. [17] Wang A, Wu H, Xu C, et al. Study on lesion assessment of cerebello-thalamo-cortical network in Wilson's disease with diffusion tensor imaging. Neural Plast, 2017, 2017: 7323121. [18] Dong T, Yang WM, Wu MC, et al. Microstructure changes in whiter matter relate to cognitive impairment in Wilson's disease. Biosci Rep, 2019, 15: 39(3). pii: BSR20181651. [19] HuS, Wu H, Xu C, et al. Aberrant coupling between resting-state cerebral blood flow and functional connectivity in Wilson's disease. Front Neural Circuits, 2019, 13: 25. [20] koloudík D, Mašková J, Dušek P, et al. Digitized image analysis of insula echogenicity detected by TCS-MR fusion imaging in Wilson's and early-onset Parkinson's diseases. Ultrasound Med Biol, 2020[ahead of print] . [21] Quick S, Reuner U, Weidauer M, et al. Cardiac and autonomic function in patients with Wilson's disease. Orphanet J Rare Dis, 2019, 14(1): 22. [22] Quick S, Weidauer M, Heidrich FM, et al. Cardiac manifestation of Wilson's disease. J Am Coll Cardiol, 2018, 72(22): 2808-2809. [23] Zhang K, Reuner U, Weidauer M, et al. Left ventricular clefts - incidental finding or pathologic sign of Wilson's disease? Orphanet J Rare Dis, 2019, 14(1): 244. [24] Paranawithana NN, Martins AF, Clavijo Jordan V, et al. A responsive magnetic resonance imaging contrast agent for detection of excess copper (II) in the liver in vivo. J Am Chem Soc, 2019, 141(28): 11009-11018. |